B-19 Orwa Albitar Pharmacometric Modeling of Drug Adverse Effects: An Application of Mixture Models in Schizophrenia Spectrum Disorder Patients Treated with Clozapine Wednesday 16:40-17:00 |
B-20 Jurgen Langenhorst An item response theory model with bounded integer subcomponents to describe the Mayo Clinic subscores in patients with ulcerative colitis Wednesday 17:00-17:20 |
C-08 Marie Alexandre SARS-CoV-2 mechanistic correlates of protection in non-human primates: insight from modelling response to vaccines. Thursday 11:20-11:40 |
C-09 Alexandra Lavalley-Morelle Longitudinal biomarkers predicting death of hospitalized patients for SARS-COV-2 infection: a joint analysis with competing risks Thursday 11:40-12:00 |
C-10 Jacqueline Ernest Spatially and temporally resolved diffusion kinetics of bedaquiline and TBAJ-587 in hard-to-treat sites of TB disease Thursday 12:00-12:20 |
C-11 Federico Reali PBPK/PD modeling and machine learning approaches to support the development of new drugs and regimens against tuberculosis. Thursday 12:20-12:40 |